Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUTI Immunotherapy in Tuberculosis
NCT05136833Phase 2Withdrawn
- Sponsor
- Archivel Farma
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
A Phase 2 trial of RUTI vaccine in Tuberculosis (TB), sponsored by Archivel Farma. Planned start Dec 2021; status: withdrawn.
02
Drugs
RUTI vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05136833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136833.